Successful CFDA Inspection
Pharmaron’s Toxicology and Safety Pharmacology (TSP) site, located in Beijing, passed the CFDA GLP inspection and received the GLP certificate in June 2017.
This is the third CFDA GLP inspection of the TSP site, as part of the CFDA GLP re-inspection program. The success of the GLP inspection allows Pharmaron to significantly expand its capacities to accommodate the increasing business volume in the safety assessment area. This includes supporting CFDA IND filings and dual IND filings with CFDA and another international regulatory agency, such as US FDA and OECD member agencies. Our TSP site has passed inspections twice by US FDA, once by EMA and once by Belgium GLP Bureau.
Learn more about our small molecule services
